Bombesin enhances TGF-beta growth inhibitory effect through apoptosis induction in intestinal epithelial cells

Regul Pept. 2009 Nov 27;158(1-3):26-31. doi: 10.1016/j.regpep.2009.07.010. Epub 2009 Jul 23.

Abstract

Mammalian intestinal epithelium undergoes continuous cell turn over, with cell proliferation in the crypts and apoptosis in the villus. Both transforming growth factor (TGF)-beta and gastrin-releasing peptide (GRP) are involved in the regulation of intestinal epithelial cells for division, differentiation, adhesion, migration and death. Previously, we have shown that TGF-beta and bombesin (BBS) synergistically induce cyclooxygenase-2 (COX-2) expression and subsequent prostaglandin E(2) (PGE2) production through p38(MAPK) in rat intestinal epithelial cell line stably transfected with GRP receptor (RIE/GRPR), suggesting the interaction between TGF-beta signaling pathway and GRPR. The current study examined the biological responses of RIE/GRPR cells to TGF-beta and BBS. Treatment with TGF-beta1 (40 pM) and BBS (100 nM) together synergistically inhibited RIE/GRPR growth and induced apoptosis. Pretreatment with SB203580 (10 microM), a specific inhibitor of p38(MAPK), partially blocked the synergistic effect of TGF-beta and BBS on apoptosis. In conclusion, BBS enhanced TGF-beta growth inhibitory effect through apoptosis induction, which is at least partially mediated by p38(MAPK).

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Blotting, Western
  • Bombesin / pharmacology*
  • Cell Cycle
  • Cell Line
  • Epithelial Cells / drug effects
  • Intestinal Mucosa / cytology
  • Intestinal Mucosa / drug effects*
  • Rats
  • Transforming Growth Factor beta / pharmacology*
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Transforming Growth Factor beta
  • p38 Mitogen-Activated Protein Kinases
  • Bombesin